Plain-language articles on the trends that matter — naloxone (Narcan) access, fentanyl and overdose data, mental health, and substance use — drawn from trusted sources across the country. Subscribe and we'll email you each time we publish something new.
August 7, 2026
A spotlight on Drew Roletti, CADC, founder of Bridgecrest Behavioral Health — anger management, court-recognized batterers intervention, and CADC addiction counseling. The deeper work lasting recovery depends on.
July 13, 2026
U.S. teen drug and alcohol use has hit historic lows for five straight years. But fentanyl-laced counterfeit pills create a deadly danger even for youth who rarely use substances. What parents and communities need to know.
July 6, 2026
Veterans face higher rates of alcohol use disorder and opioid-related harm than civilians — driven by trauma, chronic pain, and the pressures of military life. Here's what the data shows and how to find help.
July 5, 2026
A veterinary sedative called xylazine is being mixed into street drugs — often without the user's knowledge. It doesn't respond to Narcan, causes severe wounds, and has been found in 49 states. Here's what communities need to know.
June 28, 2026
U.S. overdose deaths dropped nearly 27% in 2024, the largest decline on record. Here's what's driving it, why fentanyl is down while stimulants are up, and what it means for families.
June 14, 2026
Naloxone is now over the counter nationwide, and free in every state. A step-by-step guide to getting it, recognizing an overdose, and using nasal-spray Narcan.
July 2, 2026
Tens of millions of Americans live with a mental illness, a substance use disorder, or both. Why co-occurring conditions are so common — and how whole-person care helps.
The Empower Brief shares public-health information from trusted national sources. It is educational and is not medical advice. In an emergency, call 911. For substance use and mental health support, call or text 988 or call SAMHSA's helpline at 1-800-662-4357.